Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SepSolve Analytical is a commercial analytical instrumentation and software company focused on gas chromatography, comprehensive two-dimensional gas chromatography, mass spectrometry, sample introduction, and data-analysis workflows. The company sells tools and application support for laboratories working in areas including biomarker discovery, environmental analysis, food and flavor science, petrochemical testing, and related separation-science applications. Its product portfolio includes the INSIGHT flow modulator for GC×GC, BenchTOF time-of-flight mass spectrometry systems, and ChromSpace/ChromCompare software, alongside autosampling and sample-preparation solutions. SepSolve is not a drug developer; it is a life-science tools and analytical platform provider serving commercial, academic, and government laboratories. In January 2026, SepSolve Analytical became part of the Velaris laboratory-automation group through Velaris' acquisition of Markes International and SepSolve Analytical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SepSolve Analytical.